These Four Small Caps Are on Our Radar This Week
May 04 2016 - 7:30AM
InvestorsHub NewsWire
NEW YORK, NY -- May 3, 2016 --
Investors Hub NewsWire – http://www.BroadStreetAlerts.com
monitors and scans the markets for stock related signals as well as
any external factors that might bring trading opportunities.
Through a vast network of IR professionals
www.Broadstreetalerts.com is often on the lookout for large
investor awareness campaigns being deployed.
To subscribe by phone and receive
messages directly to your mobile phone in real time, text keyword
"Alerts" to 25827.
Click the link below for the full Due
Diligence report.
Shares of Cardinal Resources, Inc.
(OTCBB: CDNL) jumped 30% in yesterday’s trading session with share
volume double the daily average trading 31 million shares.
Northwest Biotherapeutics (NASDAQ: NWBO) has issued an update on
clinical trials for its DCVax tumor therapy. Paragon Shipping, Inc.
(NASDAQ: PRGN) saw share volume increase by a factor of four
following information on corporate actions and Amarin Corp. PLC
(NASDAQ: AMRN) was up 6% as investors await Q1 results due out on
May 5th. Full Report- http://broadstreetalerts.com/dd-amrn-cdnl-nwbo-prgn/
About Broad Street Alerts
We make the connection between
sophisticated investors and high quality micro and small cap
companies. An issuer of reports that provide a straightforward
assessment of the profiled company. They include stocks traded in
the NYSE, NASDAQ, and OTCBB exchanges.
Safe Harbor Statement
This press release may include
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements
related to anticipated revenues, expenses, earnings, operating cash
flows, the outlook for markets and the demand for products.
Forward-looking statements are no guarantees of future performance
and are inherently subject to uncertainties and other factors which
could cause actual results to differ materially from the
forward-looking statements. Such statements are based upon, among
other things, assumptions made by, and information currently
available to, management, including management's own knowledge and
assessment of the Company's industry and competition. The Company
refers interested persons to its most recent Annual Report on Form
10-K and its other SEC filings for a description of additional
uncertainties and factors, which may affect forward-looking
statements. The company assumes no duty to update its
forward-looking statements
Compliance
Procedure
Content is researched, written and
reviewed on a best-effort basis by a 3rd party research analyst.
However, we are only human and may make mistakes. This report was
prepared for informational purposes only. A full disclaimer
can be found by viewing the full analyst report. We do not hold any
positions and have not been compensated in any form for this press
release and coinciding reports. For more information and services
provided beyond this press release please use contact information
provided below. If you notice any errors or omissions, please
notify us.
Source: Broad Street Alerts
Contact: editor@broadstreetalerts.com
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Nov 2023 to Nov 2024